Abstract:Introduction The study aims to explore the utility of BDNF Val66Met polymorphism as a potential biomarker in Indian bipolar disorder patients and its correlation with clinical characteristics. Objectives Genotyping Val66Met in BDNF gene Exploring its association with bipolar disorder (BD). Methods 150 consenting BD patients and matched controls were recruited using a case-control study design. BD severity was assessed using Young's mania rating scale and the Clinical Global Impression - Severity (CGI-S) scale. BDNF Val66Met polymorphism was identified through real-time PCR after DNA extraction. Data was tested for normal distribution. Genotype frequencies between two groups were compared and the Hardy-Weinberg equilibrium assumptions were tested using Chi-Square tests. Clinical-genotypic associations were explored using the Kruskal-Wallis test and confirmed using hierarchical regression. Results Our sample had more males (60%) than females (40%) with mean age of 35.05 years. Most patients had established bipolar disorder and were severely ill (CGI: 38.75, YMRS). Val66Met SNP genotype frequency differed significantly between cases and controls. Val66Val genotype and Val allele were higher in cases. Results consistent with Hardy-Weinberg equilibrium. Table 1. Genotype frequencies of BDNF (rs6265) in cases and controls GENOTYPE CC CT TT CASES 94(62.6%) 47(31.3%) 9(6%) CONTROL 71(47.3%) 69(46%) 10(6.6%) CHI-SQUARE- 7.431 DF(Degree of freedom) - 2 p-value- 0.024 Table 2. Dominant genotype frequencies in cases and controls DOMINANT GENOTYPE CC CT+TT CASES 94(62.6%) 56(37.3%) CONTROLS 71(47.3%) 79(52.6) CHI-SQUARE-7.125 DF(Degree of freedom)-1 p-value-0.007 Table 3. Allelic frequencies of BDNF (rs6265) in BD cases and healthy controls ALLELIC VARIATION C T CASES 235(78.3%) 65(21.6%) CONTROLS 211(70.3%) 89(29.6%) CHI-SQUARE-5.032 DF(Degree of freedom)-1 p-value- 0.024 Conclusions Our study found that Val66Val genotype and Val allele were higher in cases and could be a potential biomarker for bipolar disorder (BD), which is consistent with previous research conducted on the European population. However, further investigations are required to gain a more comprehensive understanding of its impact on BD, including its association with serum BDNF levels, treatment outcomes, and a more diverse study population. Disclosure of Interest None Declared

Bdnf Val66met Polymorphism Is Associated With Stage Iiiiv Endometriosis And Poor In Vitro Fertilization Outcome

Association Of Brain-Derived Neurotrophic Factor Genetic Val66met Polymorphism With Severity Of Depression, Efficacy Of Fluoxetine And Its Side Effects In Chinese Major Depressive Patients

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.

Interleukin-10 Gene Promoter Polymorphisms and Their Protein Production in Peritoneal Fluid in Patients with Endometriosis

Research on Relationship Between Gene Polymorphisms of Interleukin-1 Family and Endometriosis

Outcome of in vitro fertilization in endometriosis-associated infertility: a 5-year database cohort study.

Relationship Between IL-10 Promoter Gene Polymorphisms and the Susceptibility to Endometriosis

BDNF Val66Met Was Associated with the Susceptibility of PE but Irrespective of Neonatal Poor Prognosis in a Han Population：a Case-Control Study

Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis

The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis.

Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI

Inherited White Matter Disorders of Childhood: A Magnetic Resonance Imaging–Based Pattern Recognition Approach

Transcriptome profiling analysis of the mechanisms underlying the BDNF Val66Met polymorphism induced dysfunctions of the central nervous system

BDNFVal66met polymorphism: a potential bridge between depression and thrombosis

Positive Association Between the Brain-Derived Neurotrophic Factor (bdnf) Gene and Bipolar Disorder in the Han Chinese Population

Brain-derived neurotrophic factor Val66Met genotype and ovarian steroids interactively modulate working memory-related hippocampal function in women: a multimodal neuroimaging study

BDNF val66met Polymorphism Impairs Hippocampal Long-Term Depression by Down-Regulation of 5-HT3 Receptors.

Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants

The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy

The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.

Comparison of Val66met Polymorphism of BDNF gene in patients of bipolar disorder and healthy controls.